CYP2D6 polymorphisms influence tamoxifen treatment outcomes in

Biology, Free Full-Text

CYP2D6 Genotyping for Personalized Therapy of Tamoxifen in Indonesian Women with ER+ Breast Cancer

The frequencies of CYP2D6 alleles and their impact on clinical outcomes of adjuvant tamoxifen therapy in Syrian breast cancer patients, BMC Cancer

CYP2D6 genotype predicts tamoxifen discontinuation and drug response: a secondary analysis of the KARISMA trial - ScienceDirect

Pharmacogenomics of breast cancer: highlighting CYP2D6 and tamoxifen

CYP2D6 gene variants: association with breast cancer specific survival in a cohort of breast cancer patients from the United Kingdom treated with adjuvant tamoxifen, Breast Cancer Research

The frequencies of CYP2D6 alleles and their impact on clinical outcomes of adjuvant tamoxifen therapy in Syrian breast cancer patients, BMC Cancer

CYP2D6 polymorphisms and the impact on tamoxifen therapy - Journal of Pharmaceutical Sciences

CYP2D6 polymorphisms and their influence on risperidone treatment

The frequencies of CYP2D6 alleles and their impact on clinical outcomes of adjuvant tamoxifen therapy in Syrian breast cancer patients, BMC Cancer

Frontiers Clinical Trial: CYP2D6 Related Dose Escalation of Tamoxifen in Breast Cancer Patients With Iranian Ethnic Background Resulted in Increased Concentrations of Tamoxifen and Its Metabolites